⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IFRX News
InflaRx N.V. Common Stock
InflaRx Announces November Investor Events
globenewswire.com
IFRX
InflaRx Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026
globenewswire.com
IFRX
Pyoderma Gangrenosum Pipeline Report 2026: Spesolimab Leads in Phase III as IL-36 Blockade Targets Unmet Need
globenewswire.com
IBN
IFRX
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
globenewswire.com
IFRX
InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
globenewswire.com
IFRX
InflaRx to Host Virtual Capital Markets Day
globenewswire.com
IFRX
InflaRx Announces Participation in September Investor Conferences
globenewswire.com
IFRX
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
globenewswire.com
IFRX
InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones
globenewswire.com
IFRX
InflaRx to Report Second Quarter 2026 Results on August 6, 2026
globenewswire.com
IFRX